American Society of Hematology

Highlights of ASH

Attend one of eight Highlights of ASH meetings featuring expert analysis of the 56th ASH Annual Meeting abstracts and sessions.

Learn more

CME Credit and Certificate of Attendance

Obtain CME credit and a certificate of attendance for the 56th ASH Annual Meeting by April 17, 2015.

Learn more

ASH Meeting on Hematologic Malignancies

Hear top experts in hematologic malignancies discuss the latest developments in clinical care.

Learn more

Protect Medical Research

Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.

Take action
Find a Hematologist

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more
Support Hematology

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more
Join ASH

ASH Membership

Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.

Learn more
View all press releases
  • SGR – Where Do We Go from Here?

    As the 113 th Congress winds down, it has become clear that this group of legislators will not be remembered as the one that permanently addressed the issues associated with Medicare physician payment.  Read more to find out what may happen with the SGR in 2015.

  • Friends of Cancer Research and Brookings Institution Address Oncology Drug Development at a Conference on Clinical Cancer Research

    The seventh-annual Conference on Clinical Cancer Research brought together leaders in cancer drug development from federal, health and regulatory agencies, academic research and the private sector for focused discussions on critical issues surrounding the development and regulation of cancer drugs and therapies.

  • ASH Pleased by Newly Released NHLBI Funding Opportunities for Stem Cell-Derived Blood Products for Therapeutic Use

    The National Heart, Lung and Blood Institute (NHLBI) is now accepting applications for  R01  Research Project Grants and  R41 / R43/44  Small Business Technology Transfer Grants that will support research addressing scientific questions to enable and accelerate the use of stem cell-derived blood products as therapeutics.  The application deadlines for these funding opportunities is February 15 and February 20, 2015, respectively.

  • Laboratory-Developed Tests and the FDA

    The FDA recently indicated that it wishes to begin to provide regulatory oversight of some laboratory-developed tests.  FDA is clear to indicate that it does not wish to include all tests in the regulatory process, and that it wishes to phase in this process over a period of years, starting with those tests that are most high risk. ASH is closely reviewing this proposed guidance in order to prepare comments for submission to the agency.

View all policy news
  • November-December Editor's Choice

    Dr. Bob Löwenberg (Editor-in-Chief) and Dr. Nancy Berliner (Deputy Editor-in-Chief) have combined efforts to identify some of the most outstanding Blood articles that have appeared either in print or online during the two-month interval between issues of The Hematologist. The goal is to underscore the remarkable research that is published in Blood and to highlight the exciting progress that is being made in the field.

  • Aplastic Anemia and Advocacy for Some Uniquely Pediatric Issues

    Dr. Bertuch and Dr. Kurre examine the need for improvement in how acquired aplastic anemia is both diagnosed and treated in the United States.

  • ASH Launches New Publication for Clinicians

    This fall, ASH will begin publishing a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology. ASH Clinical News will provide timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature.

  • Looking Back – Looking Forward: 40 Years in Hemophilia Research

    Dr. Gilbert White chronicles his involvement in the HIV and HCV epidemics that devastated the hemophilia population in the 1980s, highlighting the power of science and the resilience of patients, physicians, and scientists, who faced adversity and triumphed.

View all Hematologist articles